Ez Aldeen Esawi

Ez Aldeen Esawi

Higher Degree by Research Candidate

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences

  • Journals
    Year Citation
    2024 Alkhawaja, B., Abuarqoub, D., Al-Natour, M., Alshaer, W., Abdallah, Q., Esawi, E., . . . Watts, A. G. (2024). Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery. Bioconjugate Chemistry, 35(10), 1491-1502.
    DOI
    2023 Esawi, E. I., Mahmoud, I. S., Abdullah, M. S., Abuarqoub, D. A., Ahram, M. A., & Alshaer, W. M. (2023). 1,4-Naphthoquinone Induces FcRn Protein Expression and Albumin Recycling in Human THP-1 Cells. ACS Omega, 8(18), 16491-16499.
    DOI Scopus4 WoS3
    2023 Abuarqoub, D., Mahmoud, N., Alshaer, W., Mohammad, M., Ibrahim, A. A., Al-Mrahleh, M., . . . Awidi, A. (2023). Biological Performance of Primary Dental Pulp Stem Cells Treated with Gold Nanoparticles. Biomedicines, 11(9), 1-15.
    DOI Scopus2 WoS2 Europe PMC1
    2023 Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., . . . Sedaghati-Khayat, B. (2023). Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature, 621(7977), E7-E26.
    DOI Scopus53 WoS66 Europe PMC59
    2023 Nsairat, H., Alshaer, W., Odeh, F., Esawi, E., Khater, D., Bawab, A. A., . . . Mubarak, M. S. (2023). Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. Opennano, 11, 100132.
    DOI Scopus75
    2023 Alshaer, W., Nsairat, H., Lafi, Z., Hourani, O. M., Al-Kadash, A., Esawi, E., & Alkilany, A. M. (2023). Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules, 28(1), 19 pages.
    DOI Scopus41 WoS35 Europe PMC20
    2022 Al-Azzawi, H., Alshaer, W., Esawi, E., Lafi, Z., Abuarqoub, D., Zaza, R., . . . Awidi, A. (2022). Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. Journal of Drug Delivery Science and Technology, 69, 11 pages.
    DOI Scopus9 WoS7
    2022 The COVID-19 Host Genetics Initiative., & Ganna, A. (2022). A second update on mapping the human genetic architecture of COVID-19.
    DOI Europe PMC3
    2021 Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift Fur Naturforschung Section C Journal of Biosciences, 76(5), 243-250.
    DOI Scopus4 WoS4 Europe PMC3
    2021 Mahmoud, I. S., Hatmal, M. M., Abuarqoub, D., Esawi, E., Zalloum, H., Wehaibi, S., . . . Alshaer, W. (2021). 1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages. ACS Omega, 6(39), 25299-25310.
    DOI Scopus22 WoS19 Europe PMC15
    2021 Esawi, E., Alshaer, W., Mahmoud, I. S., Alqudah, D. A., Azab, B., & Awidi, A. (2021). Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells. International Journal of Molecular Sciences, 22(23), 12940.
    DOI Scopus15 WoS15 Europe PMC6
    2020 Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers chemistry: Chemical modifications and conjugation strategies. Molecules, 25(1), 51 pages.
    DOI Scopus288 WoS264 Europe PMC175

  • Book Chapters
    Year Citation
    2022 Esawi, E., Nsairat, H., Mahmoud, I. S., Lafi, Z., Al-Kadash, A., Al-Ragheb, B. A., . . . Alhaer, W. (2022). Clinical use and future perspective of aptamers. In Aptamers Engineered Nanocarriers for Cancer Therapy (pp. 481-520). Elsevier.
    DOI Scopus9
    2022 Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology Next Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS.
    DOI Scopus1
Connect With Me
External Profiles